Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal dominant spastic paraplegia type 42 is a pure form of hereditary spastic paraplegia characterized by slowly progressive spastic paraplegia of lower extremities with an age of onset ranging from childhood to adulthood and patients presenting with spastic gait, increased tendon reflexes in lower limbs, extensor plantar response, weakness and atrophy of lower limb muscles and, in rare cases, pes cavus. No abnormalities are noted on magnetic resonance imaging.
Features include very common findings: Babinski sign, Spastic gait, Overactive reflexes (hyperreflexia), and Lower limb spasticity and others; and common findings: Impaired vibration sensation in the lower limbs, Clonus, Lower limb amyotrophy, and Lower limb muscle weakness and others. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Babinski sign, Lower limb hyperreflexia, Spastic gait |
Arms and legs | 6 | Lower limb hyperreflexia, Lower limb spasticity, Lower limb hypertonia |
Muscles | 3 | Skeletal muscle atrophy, Muscle weakness, Lower limb muscle weakness |
Bones and joints | 1 | Skeletal muscle atrophy |
Huppke-Brendel syndrome (HBS) is characterized by congenital cataracts, sensorineural hearing loss, and severe developmental delay in all reported children. One adult presented with less severe features. To date, 11 individuals (ten children and one adult) with HBS have been reported in the literature [, , , , , , ]. Ocular features. Bilateral congenital cataracts were reported in all affected individuals. Affected individuals presented with poor visual fixation and rotary nystagmus. Two individuals underwent cataract extraction in early infancy; there was improvement in visual fixation and nystagmus in one child and no improvement in vision in the other . Sensorineural hearing loss manifests during infancy. Brain stem auditory evoked potentials in two individuals showed absent waveforms.
Source: GeneReviews — "Huppke-Brendel Syndrome"
SLC33A1 function has not been fully characterized.
Hereditary spastic paraplegia 42 is associated with mutations in the SLC33A1 gene on chromosome 3.
Formal diagnostic criteria for Huppke-Brendel syndrome (HBS) have not been established.
HBS should be suspected in individuals with the following clinical, radiographic, electrophysiologic, and laboratory findings.
Clinical findings
Bilateral congenital cataracts
Nystagmus
Sensorineural hearing loss
Severe developmental delay/ intellectual disability and regression of acquired milestones
Hypotonia
Seizures
Poor weight gain and growth deficiency
Radiographic findings (on brain MRI examination)
Cerebellar hypoplasia/ cerebellar atrophy
Cerebral atrophy
Hypomyelination/dysmyelination
White matter volume loss
Wide subarachnoid spaces
Posterior cranial fossa cyst
Electrophysiologic findings. Brain stem auditory evoked potentials show absent wave forms.
Laboratory findings
Source: GeneReviews — "Huppke-Brendel Syndrome"
Disorders with low copper and ceruloplasmin in the differential diagnosis of Huppke-Brendel Syndrome are listed in . Table 2. Differential Diagnosis of Huppke-Brendel Syndrome: Disorders of Copper Metabolism
Gene | Disorder | MOI | Features of Disorder |
|---|---|---|---|
AP1S1 | IDEDNIK syndrome (MEDNIK syndrome) | AR | serum ceruloplasmin total copper levels are common.; Hearing loss, DD/ID, cataracts (2 persons), sparse hair, hypotonia |
ATP7A | Menkes syndrome (See ATP7A-Related Copper Transport Disorders.) |
Genetic testing for SLC33A1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hereditary spastic paraplegia 42 has been reported in the published literature.
No approved treatments are currently available for hereditary spastic paraplegia 42. The disease remains an area of unmet medical need.
No clinical practice guidelines for Huppke-Brendel syndrome (HBS) have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with HBS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 3.
Huppke-Brendel Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
Eyes | Ophthalmology eval | To assess for cataracts, reduced vision, abnormal ocular movement, best corrected visual acuity, refractive errors, strabismus
| Audiology eval | Incl brain stem auditory evoked response otoacoustic emissions testing
| • Complete neurologic assessment
EEG if seizures are suspected
|
Gastrointestinal/
| Gastroenterology/ nutrition/ feeding team eval | • To incl eval of aspiration risk nutritional status
Consider eval for gastrostomy tube placement in persons w/dysphagia /or aspiration risk.
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:
Source: GeneReviews — "Huppke-Brendel Syndrome"
View trials for hereditary spastic paraplegia 42
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended.
Table 5.
Huppke-Brendel Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency
| Ophthalmology eval | Per treating ophthalmologist(s)
| Audiology eval | Annually or per audiologist
| • Measure growth parameters.
Evaluate nutritional status safety of oral intake.
| At each visit
| Monitor developmental progress educational needs.
| Assess for new seizures/ monitor those w/seizures as clinically indicated.
| • Physical medicine, OT/PT assessment of mobility, self-help skills
Assess for scoliosis contractures.
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning).
OT = occupational therapy; PT = physical therapy
Source: GeneReviews — "Huppke-Brendel Syndrome"
Phenotype severity distribution: 7 very common features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hereditary spastic paraplegia 42.
15 publications have been identified in PubMed for hereditary spastic paraplegia 42. Research spans Basic Science / Preclinical (40%), Epidemiology / Natural History (27%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 6 | 40% |
Disease patterns and progression | 4 | 27% |
Patient case studies | 3 | 20% |
Testing and diagnosis research | 2 | 13% |
Choi Y (2026). [PMID: 41431411](https://pubmed.ncbi.nlm.nih.gov/41431411/). *Yonsei medical journal*. [Epidemiology / Natural History]
Toyoda N (2026). [PMID: 41503587](https://pubmed.ncbi.nlm.nih.gov/41503587/). *eNeurologicalSci*. [Basic Science / Preclinical]
McClelland P (2026). [PMID: 41634041](https://pubmed.ncbi.nlm.nih.gov/41634041/). *Nature communications*. [Case Report / Case Series]
Rudenskaya GE (2025). [PMID: 40457680](https://pubmed.ncbi.nlm.nih.gov/40457680/). *Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova*. [Epidemiology / Natural History]
Yang L (2025). [PMID: 41230588](https://pubmed.ncbi.nlm.nih.gov/41230588/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Basic Science / Preclinical]
Di Folco C (2025). [PMID: 40832806](https://pubmed.ncbi.nlm.nih.gov/40832806/). *Movement disorders : official journal of the Movement Disorder Society*. [Diagnostic / Biomarker]
Li J (2025). [PMID: 40200352](https://pubmed.ncbi.nlm.nih.gov/40200352/). *Orphanet journal of rare diseases*. [Epidemiology / Natural History]
Zhang F (2025). [PMID: 39853345](https://pubmed.ncbi.nlm.nih.gov/39853345/). *Neuroradiology*. [Case Report / Case Series]
Chu X (2025). [PMID: 41164410](https://pubmed.ncbi.nlm.nih.gov/41164410/). *Frontiers in neuroscience*. [Case Report / Case Series]
Alsaleh DM (2025). [PMID: 41463620](https://pubmed.ncbi.nlm.nih.gov/41463620/). *Bioengineering (Basel, Switzerland)*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
XL |
Low serum copper ceruloplasmin concentration; Hypotonia, sparse hypopigmented hair |
Wilson disease | AR | Low serum copper ceruloplasmin concentration; urinary copper excretion | Liver disease; Movement disorder; Kayser-Fleischer rings |
CCDC115 | Congenital disorder of glycosylation, type IIo (OMIM 616828) | AR | Low serum ceruloplasmin concentration; Hypotonia, DD |
Aceruloplasminemia | AR | Low serum copper ceruloplasmin concentration; Neurologic manifestations: ataxia, involuntary movements | Retinal degeneration; Diabetes mellitus |
SLC31A1 | Neurodegeneration seizures due to copper transport defect (OMIM 620306) | AR | Low serum ceruloplasmin concentration; Low serum copper concentration in persons w/severe phenotype |
Early-onset epileptic encephalopathy, severe neurodevelopmental delay, hypotonia VMA12 (TMEM199) | Congenital disorder of glycosylation, type IIp (OMIM 616829) | AR | Low serum ceruloplasmin concentration |
Source: GeneReviews — "Huppke-Brendel Syndrome"